Calcitonin-derived carrier peptides

Current Pharmaceutical Design

Volumn 11, Issue 28, 2005, Pages 3661-3669

  Neundorf, I ^a   Beck Sickinger, A G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cell penetrating peptides; Cellular translocation; Human calcitonin; Metabolic stability; Peptide conformation

Indexed keywords

AMINOPEPTIDASE; CALCITONIN; CARBOXYPEPTIDASE; CHITIN; CYSTEINE; DAUNORUBICIN; DODECYL SULFATE SODIUM; GLYCOLIPID; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; MEMBRANE PROTEIN; METHANOL; NUCLEIC ACID; PENETRATIN; PHOSPHATIDYLGLYCEROL; PLASMID DNA; PROTEINASE; SPHINGOLIPID; VIRUS T ANTIGEN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ATOMIC FORCE MICROSCOPY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DNA TRANSFER; DRUG DELIVERY SYSTEM; DRUG DESIGN; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; INTERNALIZATION; LIPID COMPOSITION; LIPID MONOLAYER; MOLECULAR MODEL; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SIMIAN VIRUS; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; CALCITONIN; CARRIER PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 27744528178     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161205774580723     Document Type: Review

References (61)

1. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55(6): 1189-93.
2. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988; 55(6): 1179-88.
3. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 1991; 88(5): 1864-8.
4. Pontiroli AE, Alberetto M, Pozza G. Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br Med J (Clin Res Ed) 1985; 290(6479): 1390-1.
5. Silverman SL. Calcitonin. Am J Med Sci 1997; 313(1): 13-6.
6. Hirsch PF, Baruch H. Is calcitonin an important physiological substance? Endocrine 2003; 21(3): 201-8.
7. Colman E, Hedin R, Swann J, Orloff D. A brief history of calcitonin. Lancet 2002; 359(9309): 885-6.
8. National Prescription Audit Plus. Plymouth: IMS Health Plymouth Meeting; 2000.
9. Schmidt MC, Rothen-Rutishauser B, Rist B, Beck-Sickinger A, Wunderli-Allenspach H, Rubas W, et al. Translocation of human calcitonin in respiratory nasal epithelium is associated with self-assembly in lipid membrane. Biochemistry 1998; 37(47): 16582-90.
10. Stroop SD, Nakamuta H, Kuestner RE, Moore EE, Epand RM. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions. Endocrinology 1996; 137(11): 4752-6.
11. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278(1): 585-90.
12. Koppelhus U, Awasthi SK, Zachar V, Holst HU, Ebbesen P, Nielsen PE. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev 2002; 12(2): 51-63.
13. Wagner K, Van Mau N, Boichot S, Kajava AV, Krauss U, Le Grimellec C, et al. Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study. Biophys J 2004; 87(1): 386-95.
14. Wagner K, Beck-Sickinger AG, Huster D. Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR. Biochemistry 2004; 43(39): 12459-68.
15. Trehin R, Krauss U, Muff R, Meinecke M, Beck-Sickinger AG, Merkle HP. Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). Pharm Res 2004; 21(1): 33-42.
16. Trehin R, Nielsen HM, Jahnke HG, Krauss U, Beck-Sickinger AG, Merkle HP. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J 2004; 382(Pt 3): 945-56.
17. Krauss U, Kratz F, Beck-Sickinger AG. Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments. J Mol Recognit 2003; 16(5): 280-7.
18. Krauss U, Muller M, Stahl M, Beck-Sickinger AG. In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. Bioorg Med Chem Lett 2004; 14(1): 51-4.
19. Machova Z, Muhle C, Krauss U, Trehin R, Koch A, Merkle HP, et al. Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. Chembiochem 2002; 3(7): 672-7.
20. Epand RM, Epand RF, Orlowski RC, Seyler JK, Colescritt RL. Conformational flexibility and biological activity of salmon calcitonin. Biochemistry 1996; 25(8): 1964-8.
21. Kamihira M, Naito A, Tuzi S, Nosaka AY,, Saito H. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR. Protein Sci 2000; 9(5): 867-77.
22. Arvinte T, Drake AF. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants. J Biol Chem 1993; 268(9): 6408-14.
23. Bauer HH, Muller M, Goette J, Merkle HP, Fringeli UP. Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry 1994; 33(40): 12276-92.
24. Arvinte T, Cudd A, Drake AF. The structure and mechanism of formation of human calcitonin fibrils. J Biol Chem 1993; 268(9): 6415-22.
25. Epand RM, Epand RF, Orlowski RC, Schlueter RJ, Boni LT, Hui SW. Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids. Biochemistry 1993; 22(22): 5074-84.
26. Motta A, Temussi PA, Wunsch E, Bovermarm G. A 1H NMR study of human calcitonin in solution. Biochemistry 1991; 30(9): 2364-71.
27. Epand RM, Epand RF, Orlowski RC. Biologically active calcitonin analogs which have minimal interactions with phospholipids. Biochem Biophys Res Commun 1988; 152(1): 203-7.
28. Lang SR, Staudenmann W, James P, Manz HJ, Kessler R, Galli B, et al. Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI). Pharm Res 1996; 13(11):1679-85.
29. Brockman H. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions? Curr Opin: Struct Biol 1999; 9(4): 438-43.
30. Zasadzinski JA, Viswanathan R, Madsen L, Garnaes J, Schwart DK. Langmuir-Blodgett films. Science 1994; 263(5154). 1726-33.
31. Wishart DS, Sykes BD, Richards FM. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 1991; 222(2): 311-33.
32. Wishart DS, Sykes BD. Chemical shifts as a tool for structure determination. Methods Enzymol 1994; 239: 363-92.
33. Spera S, Bax A. Empirical correlation between protein backbone conformation and C.alpha. and C.beta 13C nuclear magnetic resonance. J Am Chem Soc 1991; 113(14): 5490-5492.
34. Lang S, Langguth P, Oschmann R, Traving B, Merkle HP. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol 1996; 48(11): 1190-6.
35. Lundberg P, Langel U. A brief introduction to cell-penetrating peptides. J Mol Recognit 2003; 16(5): 227-33.
36. Marsh D. Lateral pressure in membranes. Biochim Biophys Acta 1996; 1286(3): 183-223.
37. Tyagi M, Rusnati M Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001; 276(5): 3254-61.
38. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002; 277(4): 2437-43.
39. Boichot S, Krauss U, Plenat T, Rennert R, Milhiet PE, Beck-Sickinger A, et al. Calcitonin-derived carrier peptide plays a major role in the membrane localization of a peptide-cargo complex. FEBS Lett 2004; 569(1-3): 346-50.
40. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002; 66(4): 236-48.
41. Schmid SL. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem 1997; 66: 511-48.
42. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14(111-136).
43. Pike LJ. Lipid rafts: bringing order to chaos. J Lipid Res 2003; 44(4): 655-67.
44. Nichols BJ, Lippincott-Schwartz J. Endocytosis without clathrin coats. Trends Cell Biol 2001; 11: 406-412.
45. Foerg C, Ziegler U, Fernandez-Carneado J, Giralt E, Rennert R, Beck-Sickinger A, et al. Decoding the entry of two novel cell penetrating peptides (CPPs) in HeLa cells: lipid-raft mediated endocytosis and endosomal escape. Biochemistry, accepted 2004.
46. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998; 141(4): 905-15.
47. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387(6633): 569-72.
48. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1(1): 31-9.
49. Lamaze C, Dujeancourt A, Baba T, Lo CG, Benmerah A, Dautry-Varsat A. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell 2001; 7(3): 661-71.
50. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994; 266(5186): 776-9.
51. Holford M, Muir TW. Adding 'splice' to protein engineering. Structure 1998; 6(8): 951-6.
52. Perler FB, Davis EO, Dean GE, Gimble FS, Jack WE, Neff N, et al. Protein splicing elements: inteins and exteins - a definition of terms and recommended nomenclature. Nucleic Acids Res 1994; 22(7):1125-7.
53. Mathys S, Evans TC, Chute IC, Wu H, Chong S, Benner J, et al. Characterization of a self-splicing mini-intein and its conversion into autocatalytic N- and C-terminal cleavage elements: facile production of protein building blocks for protein ligation. Gene 1999; 231(1-2):1-13.
54. Mahato RI. Non-viral peptide-based approaches to gene delivery. J Drug Target 1999; 7(4): 249-68.
55. Schuster MJ, Wu GY, Walton CM, Wu CH. Multicomponent DNA carrier with a vesicular stomatitis virus G-peptide greatly enhances liver-targeted gene expression in mice. Bioconjug Chem 1999; 10(6):1075-83.
56. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 2000; 56(5): 318-25.
57. Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, et al. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 2001; 102(3):555-63.
58. Strijbos PJ, Zamani MR, Rothwell NJ, Arbuthnott G, Harkiss G. Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus. Neurosci Lett 1995; 197(3): 215-8.
59. Gotthardt M, Boermann OC, Behr TM, Behe MP, Oyen WJ. Development and clinical application of peptide-based radiopharmaceuticals. Curr Pharm Design 2004; 10(24): 2951-63.
60. Krishnadas A, Onyuksel H, Rubinstein I. Interactions of VIP, secretin and PACAP(I-38) with phospholipids: a biological paradox revisited. Curr Pharm Design 2003; 9(12): 1005-12.
61. Mehta NM, Malootian A, Gilligan JP. Calcitonin for osteoporosis and bone pain. Curr Pharm Design 2003; 9(32): 2659-76.